Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.38 |
| ▸ | PRKCG | P05129 | 2/20 | 0.38 |
| ▸ | PRKCB | P05771 | 2/20 | 0.38 |
| ▸ | PRKCA | P17252 | 2/20 | 0.38 |
| ▸ | PRKCH | P24723 | 2/20 | 0.38 |
| ▸ | PRKCI | P41743 | 2/20 | 0.38 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.38 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.38 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.38 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.38 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.38 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.36 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16841232 | 0.88 | ALDH1A1 (0.61) | ALDH1A1EPHX1PRKD3PRKCGPRKCB | |
| SCHEMBL28358812 | 0.78 | EPHX1 (0.47) | ALDH1A1EPHX1CYP1A2 | |
| SCHEMBL18177233 | 0.77 | ALDH1A1 (0.48) | ALDH1A1EPHX1PRKD3PRKCGPRKCB | |
| SCHEMBL2855219 | 0.76 | ALDH1A1 (0.40) | ALDH1A1EPHX1PRKD3PRKCGPRKCB | |
| SCHEMBL11711588 | 0.76 | ALDH1A1 (0.40) | ALDH1A1EPHX1PRKD3PRKCGPRKCB | |
| SCHEMBL7780752 | 0.76 | ALDH1A1 (0.40) | ALDH1A1EPHX1PRKD3PRKCGPRKCB | |
| SCHEMBL593048 | 0.76 | ALDH1A1 (0.40) | ALDH1A1EPHX1PRKD3PRKCGPRKCB | |
| SCHEMBL2855291 | 0.76 | ALDH1A1 (0.40) | ALDH1A1EPHX1PRKD3PRKCGPRKCB | |
| SCHEMBL31509415 | 0.76 | ALDH1A1 (0.40) | ALDH1A1EPHX1PRKD3PRKCGPRKCB | |
| SCHEMBL432739 | 0.76 | ALDH1A1 (0.40) | ALDH1A1EPHX1PRKD3PRKCGPRKCB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230226096-A1 | CIRCULAR RNA COMPOSITIONS AND METHODS | ORNA THERAPEUTICS, INC. | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230226096-A1 | CIRCULAR RNA COMPOSITIONS AND METHODS | RTCB, HNRNPA1, HNRNPAB | ALDH1A1 4484/4885EPHX1 4437/4885PRKD3 3037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.